Saturday 17 October 2026
Export SOPH’s income statement to Excel — free account
SOPHiA GENETICS SA
SOPH Healthcare Health Information Services
SOPHiA GENETICS SA’s revenue for fiscal 2025 (year ended December 2025) was $77.3 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue grew 27.2%, EPS grew 9.88%, free cash flow grew 6.50% and total debt rose 1.12%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
6.73
0.56
−7.68%
Follow SOPH
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 4 | 3 | 4 | 3 | 2 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | 9.87 | (0.06) | 0.54 | (2.33) | (3.43) |
P/S ratio |
— | 24.00 | 24.00 | 19.28 | 3.03 | 5.01 | 3.11 | 4.08 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | (7.77) | 2.42 | 8.02 | 2.95 | (1.93) | (7.33) | (10.93) |
Beneish M-Score |
— | — | (2.85) | (2.70) | (2.64) | (2.20) | (3.44) | (3.30) |
P/Operating CF |
— | (50.53) | (50.53) | (50.57) | (13.96) | (27.70) | (18.98) | (38.77) |
P/B ratio |
— | 11.53 | 11.53 | 2.83 | 0.72 | 2.07 | 2.10 | 6.69 |
Price to Tangible BV |
— | 14.33 | 14.33 | 3.00 | 0.80 | 2.52 | 3.01 | 28.03 |
EV/Sales |
— | 22.24 | 22.24 | 13.04 | (0.39) | 3.30 | 2.11 | 3.81 |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.23 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (16.49) | (16.49) | (9.10) | 0.27 | (4.24) | (3.09) | (8.20) |
EV/FCF |
— | (15.91) | (15.91) | (8.68) | 0.25 | (4.09) | (3.06) | (8.04) |
Quick Ratio |
— | 1.37 | 4.80 | 9.50 | 6.91 | 3.84 | 3.27 | 1.69 |
Current Ratio |
— | 1.75 | 5.08 | 9.89 | 7.32 | 4.16 | 3.71 | 1.96 |
Net Debt/EBITDA |
— | 0.48 | 2.69 | 3.74 | 2.00 | 1.85 | 1.16 | 0.37 |
Debt/Assets |
0.00% | 7.43% | 2.52% | 3.51% | 5.76% | 0.00% | 8.52% | 29.28% |
Debt/Equity |
— | 0.17 | 0.03 | 0.04 | 0.07 | 0.00 | 0.14 | 1.01 |
Asset Turnover |
— | 0.98 | 0.31 | 0.18 | 0.17 | 0.28 | 0.36 | 0.49 |
Operating CF/Net income |
— | 0.94 | 0.81 | 0.79 | 0.80 | 0.62 | 0.71 | 0.45 |
Capex/Depreciation |
— | (1.59) | (0.32) | (0.78) | (0.82) | (0.21) | (0.05) | (0.07) |
Interest Coverage |
— | (375.43) | (389.45) | (3,574.45) | (66.33) | (127.26) | (34.80) | (15.57) |
| — | (55.05%) | (64.09%) | (39.20%) | (36.78%) | (44.93%) | (50.41%) | (110.00%) | |
| — | (130.83%) | (42.81%) | (32.58%) | (31.01%) | (35.10%) | (34.58%) | (49.63%) | |
ROIC |
— | (263.58%) | (359.77%) | (209.50%) | (154.31%) | (165.89%) | (141.03%) | (180.23%) |
Return on Tangible Assets |
— | (205.85%) | (43.77%) | (28.46%) | (49.53%) | (65.88%) | (80.31%) | (145.71%) |
Average Days of Receivables |
— | 114.11 | 81.78 | 56.65 | 51.03 | 79.34 | 41.65 | 70.86 |
Research and Development Expense of Revenue |
— | 59.21% | 65.45% | 65.71% | 74.37% | 59.27% | 52.73% | 44.28% |
Selling, General and Administrative Expense of Revenue |
— | 138.33% | 128.16% | 173.65% | 176.79% | 131.03% | 117.11% | 114.77% |
Intangible Assets out of Total Assets |
0.00 | 0.20 | 0.10 | 0.05 | 0.08 | 0.13 | 0.19 | 0.22 |
Share Based Compensation of Revenue |
— | 0.00% | 4.79% | 21.05% | 28.62% | 24.44% | 25.30% | 20.97% |
Graham Net Nets |
— | 0.06 | 0.06 | 0.31 | 1.06 | 0.30 | 0.20 | (0.05) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (6.54%) | (6.54%) | (9.39%) | (60.89%) | (25.26%) | (30.94%) | (25.12%) |
Free Cash Flow Yield |
— | (5.82%) | (5.82%) | (7.79%) | (51.76%) | (16.09%) | (22.17%) | (11.61%) |
Revenue per Share |
— | 0.67 | 0.67 | 0.73 | 0.74 | 0.96 | 0.99 | 1.14 |
Operating CF per Share |
— | (0.84) | (0.75) | (1.05) | (1.09) | (0.75) | (0.67) | (0.53) |
Capex per Share |
— | (0.08) | (0.02) | (0.05) | (0.07) | (0.03) | (0.01) | (0.01) |
Free Cash Flow per Share |
— | (0.92) | (0.77) | (1.10) | (1.16) | (0.78) | (0.68) | (0.54) |
Cash per Share |
— | 0.49 | 2.30 | 4.80 | 2.79 | 1.90 | 1.21 | 1.04 |
Shareholders Equity per Share |
— | 0.59 | 2.37 | 4.98 | 3.12 | 2.34 | 1.46 | 0.70 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.59 | 2.37 | 4.98 | 3.12 | 2.34 | 1.46 | 0.70 |
Free Cash Flow |
— | (34.71) | (32.50) | (60.75) | (74.65) | (50.33) | (44.95) | (36.57) |
Working Capital |
— | 14.50 | 88.11 | 254.25 | 169.45 | 112.43 | 72.60 | 48.55 |
Capital Expenditures |
— | (3.03) | (0.77) | (2.81) | (4.56) | (1.76) | (0.44) | (0.68) |
Net Current Asset Value |
— | 4.36 | 78.09 | 238.08 | 152.55 | 93.33 | 40.59 | (16.81) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.21 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.12 | 0.03 | 0.07 | 0.10 | 0.03 | 0.01 | 0.01 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 1.00 | 1.35 | 0.77 | 0.78 | 1.12 | 1.65 | 1.68 |
Cash ROIC |
— | (77.96%) | (16.15%) | (11.01%) | (19.01%) | (18.32%) | (23.67%) | (22.14%) |
Accounts Receivable Turnover |
— | 2.89 | 3.97 | 6.40 | 7.36 | 6.17 | 6.21 | 6.89 |
Accounts Payable Turnover |
— | 5.00 | 1.89 | 2.41 | 2.52 | 3.36 | 4.00 | 3.55 |
Inventory Turnover |
— | 2.15 | 3.06 | 3.34 | 3.00 | 3.34 | 3.44 | 4.12 |
Average Days of Payables |
— | 261.68 | 201.33 | 161.47 | 138.36 | 101.13 | 89.72 | 129.81 |
Days of Inventory on Hand |
— | 174.94 | 115.34 | 137.31 | 115.41 | 121.59 | 100.86 | 92.01 |
Average Receivables |
— | 8.78 | 7.15 | 6.32 | 6.46 | 10.10 | 10.50 | 11.22 |
Average Payables |
— | 1.51 | 5.65 | 6.32 | 6.46 | 5.79 | 5.31 | 7.09 |
Average Inventory |
— | 3.50 | 3.50 | 4.56 | 5.44 | 5.82 | 6.18 | 6.11 |
Average Assets |
— | 25.83 | 91.89 | 226.14 | 282.01 | 225.00 | 180.73 | 159.17 |
Average Common Equity |
— | 61.38 | 61.38 | 187.96 | 237.77 | 175.79 | 123.97 | 71.82 |
Columns are period end dates